The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: sandostatin     Quarter: 2016Q3

Total Records: 2,045     Number of Pages: 103

DRUGNAME PT EventCount
SANDOSTATIN Blood glucose decreased 9
SANDOSTATIN Depression 9
SANDOSTATIN Gastrooesophageal reflux disease 9
SANDOSTATIN General physical health deterioration 9
SANDOSTATIN Haematochezia 9
SANDOSTATIN Hypertension 9
SANDOSTATIN Labyrinthitis 9
SANDOSTATIN Sputum discoloured 9
SANDOSTATIN Therapeutic response decreased 9
SANDOSTATIN Underdose 9
SANDOSTATIN LAR DEPOT Abdominal adhesions 9
SANDOSTATIN LAR DEPOT Abdominal tenderness 9
SANDOSTATIN LAR DEPOT Acne 9
SANDOSTATIN LAR DEPOT Amenorrhoea 9
SANDOSTATIN LAR DEPOT Arthropathy 9
SANDOSTATIN LAR DEPOT Blood parathyroid hormone increased 9
SANDOSTATIN LAR DEPOT Blood pressure systolic decreased 9
SANDOSTATIN LAR DEPOT Bone deformity 9
SANDOSTATIN LAR DEPOT Cardiac flutter 9
SANDOSTATIN LAR DEPOT Condition aggravated 9

Total Records: 2,045     Number of Pages: 103